Mumbai, October 27 (Monday): Shares of Sigachi Industries Ltd declined 2.28% to ₹38.11 in Monday’s trade after the company reported a sharp fall in its financial performance for the second quarter of FY26. The stock slipped from its previous close of ₹39.00, taking the company’s market capitalization to ₹14.49 billion on the NSE.
The Hyderabad-based company, a key player in the pharmaceutical excipients and active pharmaceutical ingredients (APIs) segment, reported a 19% year-over-year decline in revenue, which fell to ₹1,130 million in Q2 FY26 from ₹1,395 million in Q2 FY25. Gross profit also dropped 15.72%, to ₹397.31 million from ₹471.45 million in the same quarter last year.
Q2 FY26 Financial Performance
| Metric | Q2 FY26 | Q2 FY25 | Change (YoY) |
|---|---|---|---|
| Revenue | ₹1,130 million | ₹1,395 million | ↓ 19% |
| Gross Profit | ₹397.31 million | ₹471.45 million | ↓ 15.72% |
| EBITDA | ₹75 million | ₹293 million | ↓ 74% |
| EBITDA Margin | 6.78% | 21.38% | ↓ 14.6 p.p. |
| Net Profit | ₹105 million | ₹210 million | ↓ 50% |
The company’s profitability was significantly impacted by reduced operational efficiency and higher recovery costs following the fire incident at its Pashamylaram unit on June 30, 2025. In its exchange filing, Sigachi stated that it has accelerated strategic and operational transformations to strengthen long-term resilience and profitability.
To maintain business continuity, Sigachi has reallocated production to its Dahej and Jhagadia facilities. Management noted that this has been essential in meeting customer demand and sustaining operations without major disruptions.
Notably, the company clarified that no deferred income from insurance claims has been factored into the reported results, which could potentially impact future earnings once claims are settled.
Stock Update:
- Current Price: ₹38.11
- Change: -2.28% (-₹0.89)
- Market Cap: ₹14.49 billion
- Day Range: ₹37.40 – ₹38.44
- Year Range: ₹30.51 – ₹59.59
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
